Cumberland Pharmaceuticals Net Profit Margin 2009-2020 | CPIX

Cumberland Pharmaceuticals net profit margin from 2009 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Cumberland Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.05B $-0.01B -10.64%
2020-03-31 $0.05B $-0.01B -10.87%
2019-12-31 $0.05B $-0.00B -8.51%
2019-09-30 $0.04B $-0.01B -12.20%
2019-06-30 $0.04B $-0.01B -12.82%
2019-03-31 $0.04B $-0.01B -12.50%
2018-12-31 $0.04B $-0.01B -17.50%
2018-09-30 $0.04B $-0.01B -15.38%
2018-06-30 $0.04B $-0.01B -11.90%
2018-03-31 $0.04B $-0.01B -21.95%
2017-12-31 $0.04B $-0.01B -19.05%
2017-09-30 $0.04B $-0.01B -20.51%
2017-06-30 $0.04B $-0.01B -18.92%
2017-03-31 $0.04B $-0.00B -5.71%
2016-12-31 $0.03B $-0.00B -3.03%
2016-09-30 $0.03B 0 0.00%
2016-06-30 $0.03B 0 0.00%
2016-03-31 $0.03B 0 0.00%
2015-12-31 $0.03B 0 0.00%
2015-09-30 $0.04B $0.00B 2.86%
2015-06-30 $0.04B $0.00B 5.41%
2015-03-31 $0.04B $0.00B 7.89%
2014-12-31 $0.04B $0.00B 8.11%
2014-09-30 $0.04B 0 0.00%
2014-06-30 $0.03B $-0.00B -6.06%
2014-03-31 $0.03B $-0.00B -13.33%
2013-12-31 $0.03B $-0.00B -9.38%
2013-09-30 $0.04B $0.00B 2.63%
2013-06-30 $0.04B $0.00B 9.09%
2013-03-31 $0.05B $0.01B 14.29%
2012-12-31 $0.05B $0.01B 12.24%
2012-09-30 $0.05B $0.01B 10.42%
2012-06-30 $0.05B $0.01B 10.42%
2012-03-31 $0.05B $0.01B 10.00%
2011-12-31 $0.05B $0.01B 11.76%
2011-09-30 $0.05B $0.01B 11.76%
2011-06-30 $0.05B $0.01B 10.00%
2011-03-31 $0.05B $0.00B 6.38%
2010-12-31 $0.05B $0.00B 4.35%
2010-09-30 $0.04B $0.00B 2.27%
2010-06-30 $0.05B $0.00B 2.17%
2010-03-31 $0.05B $0.00B 2.22%
2009-12-31 $0.04B $0.00B 4.55%
2009-06-30 $0.03B $0.00B 7.14%
2009-03-31 $0.03B $0.00B 11.54%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.049B $0.048B
Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.422B 43.47
Takeda Pharmaceutical (TAK) Japan $58.420B 10.18
Astellas Pharma (ALPMY) Japan $28.504B 14.44
Eisai (ESALY) Japan $26.706B 22.57
UCB SA (UCBJF) Belgium $22.660B 0.00
Merck (MKGAF) Germany $18.456B 24.20
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $13.487B 43.84
Grifols, S.A (GRFS) Spain $11.393B 13.92
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $9.111B 35.27
IPSEN SA ADR (IPSEY) France $8.650B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.741B 12.81
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Ionis Pharmaceuticals (IONS) United States $6.803B 43.10
Arrowhead Pharmaceuticals (ARWR) United States $4.594B 0.00
United Therapeutics (UTHR) United States $4.461B 10.31
Evotec AG (EVTCY) Germany $4.033B 140.00
FibroGen (FGEN) United States $3.819B 0.00
ChemoCentryx (CCXI) United States $3.633B 0.00
Hypermarcas (HYPMY) Brazil $3.496B 12.86
Sage Therapeutics (SAGE) United States $3.161B 0.00
PTC Therapeutics (PTCT) United States $3.155B 0.00
Nektar Therapeutics (NKTR) United States $3.150B 0.00
Pacira BioSciences (PCRX) United States $2.518B 66.19
Revolution Medicines (RVMD) United States $2.167B 0.00
Xencor (XNCR) United States $2.161B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.097B 10.15
Corcept Therapeutics (CORT) United States $1.975B 18.18
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.799B 0.00
Cronos Group (CRON) Canada $1.777B 0.00
USANA Health Sciences (USNA) United States $1.571B 14.80
Ironwood Pharmaceuticals (IRWD) United States $1.512B 10.50
Trillium Therapeutics (TRIL) Canada $1.345B 0.00
Heron Therapeutics (HRTX) United States $1.327B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.187B 11.31
Indivior (INVVY) United States $1.162B 14.40
Karyopharm Therapeutics (KPTI) United States $1.090B 0.00
Esperion Therapeutics (ESPR) United States $1.044B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.005B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Translate Bio (TBIO) United States $0.975B 0.00
Zogenix (ZGNX) United States $0.970B 0.00
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.877B 546.13
VAXART, INC (VXRT) United States $0.808B 0.00
Endo (ENDP) Ireland $0.753B 1.11
BioCryst Pharmaceuticals (BCRX) United States $0.643B 0.00
ImmunoGen (IMGN) United States $0.642B 0.00
Collegium Pharmaceutical (COLL) United States $0.638B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.627B 0.00
Tilray (TLRY) Canada $0.609B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.561B 0.00
Siga Technologies (SIGA) United States $0.550B 58.67
Flexion Therapeutics (FLXN) United States $0.543B 0.00
Molecular Templates (MTEM) United States $0.523B 0.00
Aerie Pharmaceuticals (AERI) United States $0.521B 0.00
Radius Health (RDUS) United States $0.509B 0.00
Ocular Therapeutix (OCUL) United States $0.497B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.484B 0.00
Ardelyx (ARDX) United States $0.480B 0.00
Altimmune (ALT) United States $0.425B 0.00
Organogenesis Holdings (ORGO) United States $0.396B 0.00
Harpoon Therapeutics (HARP) United States $0.389B 0.00
TherapeuticsMD (TXMD) United States $0.384B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.383B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.382B 19.03
Redhill Biopharma (RDHL) Israel $0.356B 0.00
Akebia Therapeutics (AKBA) United States $0.355B 0.00
DURECT (DRRX) United States $0.355B 0.00
MEI Pharma (MEIP) United States $0.351B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.327B 8.10
Innate Pharma SA (IPHYF) France $0.324B 0.00
PROFOUND MEDICL (PROF) Canada $0.324B 0.00
IMV INC (IMV) Canada $0.295B 0.00
Jounce Therapeutics (JNCE) United States $0.280B 13.27
Xeris Pharmaceuticals (XERS) United States $0.266B 0.00
Concert Pharmaceuticals (CNCE) United States $0.265B 0.00
Aquestive Therapeutics (AQST) United States $0.256B 0.00
Menlo Therapeutics (VYNE) United States $0.255B 0.00
Rafael Holdings (RFL) United States $0.255B 0.00
Calithera Biosciences (CALA) United States $0.237B 0.00
Lannett Co Inc (LCI) United States $0.236B 5.48
KalVista Pharmaceuticals (KALV) United States $0.231B 0.00
Nature's Sunshine Products (NATR) United States $0.218B 21.50
Avadel Pharmaceuticals (AVDL) Ireland $0.196B 0.00
Nivalis Therapeutics (ALPN) United States $0.195B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.194B 0.00
Heat Biologics (HTBX) United States $0.190B 0.00
CASI Pharmaceuticals (CASI) United States $0.188B 0.00
Otonomy (OTIC) United States $0.174B 0.00
OptiNose (OPTN) United States $0.172B 0.00
Taiwan Liposome (TLC) Taiwan $0.170B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.164B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.157B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.135B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Champions Oncology (CSBR) United States $0.119B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.110B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.107B 0.00
Aclaris Therapeutics (ACRS) United States $0.105B 0.00
MediWound (MDWD) Israel $0.101B 0.00
Lipocine (LPCN) United States $0.093B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
Biomerica (BMRA) United States $0.083B 0.00
CTI BioPharma (CTIC) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.076B 0.00
ElectroCore (ECOR) United States $0.072B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.071B 0.00
Novan (NOVN) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.064B 0.00
Infinity Pharmaceuticals (INFI) United States $0.063B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.053B 0.00
Onconova Therapeutics (ONTX) United States $0.052B 0.00
KemPharm (KMPH) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.050B 0.00
CV Sciences (CVSI) United States $0.050B 0.00
Recro Pharma (REPH) United States $0.049B 0.00
SCYNEXIS (SCYX) United States $0.048B 0.00
ProPhase Labs (PRPH) United States $0.044B 0.00
India Globalization Capital (IGC) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
PolarityTE (PTE) United States $0.040B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.038B 0.00
IsoRay (ISR) United States $0.037B 0.00
GTx (ONCT) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.96
Opiant Pharmaceuticals (OPNT) United States $0.033B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.033B 0.00
AgeX Therapeutics (AGE) United States $0.032B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Neos Therapeutics (NEOS) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Vical (BBI) United States $0.023B 0.00
Midatech Pharma (MTP) United Kingdom $0.022B 0.00
Sundial Growers (SNDL) Canada $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 23.36
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.009B 0.00
Shineco (TYHT) China $0.009B 0.00
JanOne (JAN) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00